Indapamid Stada

Indapamide, the active ingredient in Indapamid Stada, is a thiazide‑like diuretic presented as an oral tablet for oral use. It is employed to lower high blood pressure and to reduce fluid retention in patients with hypertension or edema related to congestive heart failure.

GNH USA supplies Indapamid Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved products to healthcare providers across multiple regions. Our distribution network ensures reliable delivery and ongoing technical support for formulary integration.

Indapamide is a thiazide‑like diuretic used in the management of cardiovascular conditions that involve fluid overload or elevated vascular resistance.

- Hypertension: lowers systolic and diastolic blood pressure to achieve target levels. - Edema associated with congestive heart failure: promotes diuresis to reduce fluid accumulation. - Primary hypertension: assists in long‑term blood pressure control and reduces cardiovascular risk.

Indapamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate intensity. - Nausea or abdominal discomfort. - Electrolyte imbalance: low potassium or sodium levels. - Increased uric acid: may precipitate gout attacks. - Photosensitivity: heightened skin reaction to sunlight.

Serious or Rare Side Effects: - Severe electrolyte disturbances: profound hypokalemia or hyponatremia. - Acute renal failure: sudden decline in kidney function. - Severe hypotension: marked drop in blood pressure causing fainting. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

- Blood pressure monitoring: ensure adequate control without excessive hypotension. - Electrolyte assessment: regularly check serum potassium and sodium levels. - Renal function: evaluate creatinine clearance, especially in patients with existing kidney disease. - Hepatic impairment: use caution in severe liver dysfunction. - Concomitant NSAIDs: may blunt diuretic effectiveness and increase renal risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can alter the pharmacokinetics or pharmacodynamics of several medicines; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - ACE inhibitors or ARBs: combined use can lead to severe hypotension and renal impairment. - NSAIDs: may reduce diuretic efficacy and worsen renal function.

Moderate Interactions (Monitor Closely): - Digoxin: enhanced serum concentrations increasing risk of toxicity. - Antidiabetic agents: potentiation of hypoglycemic effect. - Corticosteroids: may exacerbate potassium loss and electrolyte imbalance.